120 related articles for article (PubMed ID: 2071353)
1. 31P magnetic resonance spectroscopy (MRS) of experimental orbital myositis.
Winguth S; Kurhanewicz J; Wang ML; Quivey JM; James TL; Char DH
Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2417-22. PubMed ID: 2071353
[TBL] [Abstract][Full Text] [Related]
2. 31P magnetic resonance spectroscopy of animal uveal melanoma.
Kurhanewicz J; Winguth SD; Char DH; Kaleta S; Kindy-Degnan N; Swift PS; Stauffer PR; Wendland MF; Lovato A; Chang LH
Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1745-53. PubMed ID: 2211022
[TBL] [Abstract][Full Text] [Related]
3. Phorbol ester-induced orbital myositis.
Fries PD; Fohrman DS; Char DH
Arch Ophthalmol; 1987 Sep; 105(9):1273-6. PubMed ID: 3632447
[TBL] [Abstract][Full Text] [Related]
4. Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma.
Winter PM; Poptani H; Bansal N
Cancer Res; 2001 Mar; 61(5):2002-7. PubMed ID: 11280759
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the effects of high dose irradiation on canine thigh muscle by follow-up magnetic resonance imaging and phosphorus-31 magnetic resonance spectroscopy.
Choe BY; Jee WH; Suh TS; Lee HK; Shinn KS
Invest Radiol; 1998 May; 33(5):300-7. PubMed ID: 9609489
[TBL] [Abstract][Full Text] [Related]
6. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
[TBL] [Abstract][Full Text] [Related]
7. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.
Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA
Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253
[TBL] [Abstract][Full Text] [Related]
8. 31P NMR spectroscopy can predict the optimum interval between fractionated irradiation doses.
Murata O; Sakurai H; Mitsuhashi N; Hasegawa M; Yamakawa M; Kurosaki H; Hayakawa K; Niibe H
Anticancer Res; 1998; 18(6A):4297-301. PubMed ID: 9891481
[TBL] [Abstract][Full Text] [Related]
9. Radiation dose-dependent changes in tumor metabolism measured by 31P nuclear magnetic resonance spectroscopy.
Mahmood U; Alfieri AA; Thaler H; Cowburn D; Koutcher JA
Cancer Res; 1994 Sep; 54(18):4885-91. PubMed ID: 8069854
[TBL] [Abstract][Full Text] [Related]
10. [31P NMR spectroscopy of muscular diseases: correlation with MR imaging].
Kaiser WA; Hartl W; Sturm H; Schalke BC; Zeitler E
Rofo; 1987 Feb; 146(2):137-44. PubMed ID: 3029825
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic alcohol consumption on the broad phospholipid signal in human brain: an in vivo 31P MRS study.
Estilaei MR; Matson GB; Payne GS; Leach MO; Fein G; Meyerhoff DJ
Alcohol Clin Exp Res; 2001 Jan; 25(1):89-97. PubMed ID: 11198719
[TBL] [Abstract][Full Text] [Related]
12. [Idiopathic orbital myositis].
Volle E; Levy R; Miléa D; Tourbah A; Lubetzki C
Rev Neurol (Paris); 2001 Apr; 157(4):430-2. PubMed ID: 11398017
[TBL] [Abstract][Full Text] [Related]
13. Effect of cytochrome P450 induction on phosphorus metabolites and proton relaxation times measured by in vivo 31P-magnetic resonance spectroscopy and 1H-magnetic resonance relaxometry in human liver.
Block W; Reichel C; Träber F; Skodra T; Lamerichs R; Kreft B; Spengler U; Sauerbruch T; Schild HH
Hepatology; 1997 Dec; 26(6):1587-91. PubMed ID: 9398002
[TBL] [Abstract][Full Text] [Related]
14. [Phosphorus 31-magnetic resonance spectroscopic studies of animal liver after extracorporeal shock wave lithotripsy].
Yokota H; Matoba M; Tatsuta N; Tonami H; Okimura T; Yamamoto I
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jul; 52(7):934-41. PubMed ID: 1508653
[TBL] [Abstract][Full Text] [Related]
15. 31P magnetic resonance spectroscopy demonstrates expansion of the extracellular space in the skeletal muscle of starved rats.
Mizobata Y; Rounds JD; Prechek D; DeRosa E; Wilmore DW; Jacobs DO
J Surg Res; 1994 Jun; 56(6):491-9. PubMed ID: 8015301
[TBL] [Abstract][Full Text] [Related]
16. Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review.
Kemp GJ; Meyerspeer M; Moser E
NMR Biomed; 2007 Oct; 20(6):555-65. PubMed ID: 17628042
[TBL] [Abstract][Full Text] [Related]
17. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances.
Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; Burroughs AK; Morgan MY
Hepatology; 1995 Feb; 21(2):417-27. PubMed ID: 7843715
[TBL] [Abstract][Full Text] [Related]
18. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study.
Sterin M; Cohen JS; Mardor Y; Berman E; Ringel I
Cancer Res; 2001 Oct; 61(20):7536-43. PubMed ID: 11606391
[TBL] [Abstract][Full Text] [Related]
19. Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy.
Dewhirst MW; Poulson JM; Yu D; Sanders L; Lora-Michiels M; Vujaskovic Z; Jones EL; Samulski TV; Powers BE; Brizel DM; Prosnitz LR; Charles HC
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):480-91. PubMed ID: 15667971
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo 31P nuclear magnetic resonance measurements of metabolic changes post radiation.
Mahmood U; Alfieri AA; Ballon D; Traganos F; Koutcher JA
Cancer Res; 1995 Mar; 55(6):1248-54. PubMed ID: 7882317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
